Discover

KAPA
Kairos Pharma, Ltd.
0.37
1000 x undefined
100 x undefined
bid
ask
-
0.02
4.07%
550 @ 05:55 AM
0.37 -0.00 (0.79%)
Ytd-48.15%
1y-47.41%
0.37
day range
0.40
0.33
52 week range
2.11
Open0.38Prev Close0.38Low0.37High0.40Mkt Cap7.88M
Vol72.09KAvg Vol135.11KEPS-0.30P/EN/AForward P/E-7.46
BetaN/AShort Ratio0.13Inst. Own0.10%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg0.50200-d Avg0.741yr Est9.00
Income Statement
Operating Expenses1.69M
Research and Development Expense684.00K
Selling, General and Administrative Expense1.01M
Operating Income-1.69M
Net Income-1.65M
Net Income Common Stock-1.65M
Net Income Common Stock (USD)-1.65M
Consolidated Income-1.65M
Earnings per Basic Share-0.08
Earnings per Basic Share (USD)-0.08
Earnings per Diluted Share-0.08
Earning Before Interest & Taxes (EBIT)-1.65M
Earning Before Interest & Taxes (USD)-1.65M
Weighted Average Shares21.01M
Weighted Average Shares Diluted21.01M
Balance Sheet
Cash and Equivalents3.68M
Cash and Equivalents (USD)3.68M
Current Assets4.44M
Total Assets5.74M
Current Liabilities431.00K
Total Liabilities431.00K
Accumulated Retained Earnings (Deficit)-15.92M
Shareholders Equity5.31M
Shareholders Equity (USD)5.31M
Assets Non-Current1.30M
Goodwill and Intangible Assets22.00K
Trade and Non-Trade Payables431.00K
Cash Flow
Depreciation, Amortization & Accretion40.00K
Net Cash Flow from Financing220.00K
Net Cash Flow / Change in Cash & Cash Equivalents-816.00K
Issuance (Purchase) of Equity Shares385.00K
Net Cash Flow from Operations-1.04M
Share Based Compensation259.00K